Home
Martine A. Rothblatt, Chairperson & CEO: United Therapeutics UTHR Sell · Filed 06/02
Trade details
- Type
- Insider sale
- Amount
- $1,208,762.73
- Shares · price
- 2,213 sh · $546.21 a share
- Held after
- 46,435 sh
- Trade date
- 26/06/01
- Filed
- 26/06/02
- Days to filing
- 1 days
Sold 4.5% of holdings
- Share of holding sold
- 4.5%
United Therapeutics trades, last 26 weeks
What else happened in United Therapeutics around then
Filed or reported within 30 days of the trade day · 05/02~07/01Martine A. Rothblatt's recent trades
- Martine A. Rothblatt
Planned sale10b5-1 planUnited Therapeutics
Planned sale10b5-1 planUnited Therapeutics
UTHR
$113.3M
209,000 sh
$113.3M
Filed 10/01
Traded 10/01
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$1.1M
2,309 sh
$1.1M
Filed 09/30
Traded 09/29
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$1M
2,135 sh
$1M
Filed 09/30
Traded 09/29
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$664.2K
1,395 sh
$664.2K
Filed 09/30
Traded 09/29
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$574.9K
1,200 sh
$574.9K
Filed 09/30
Traded 09/29